Wissenschaftliche Arbeiten
Doç. Dr. Mehmet Orkun Sevik
57 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.
-
Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema
European Journal of Ophthalmology, 2026
DOI 10.1177/11206721261480211 PMID 42630057 Frei zugänglicher VolltextQuelle: OpenAlex
-
Ocular and Psychosocial Outcomes After Pediatric Open Globe Injury Repair
Research Square, 2026
DOI 10.21203/rs.3.rs-9188151/v1 Frei zugänglicher VolltextQuelle: OpenAlex
-
Comparison of Optical Coherence Tomography Biomarkers in Nonproliferative and Proliferative Diabetic Retinopathy: Marmasia Study Group Report No. 2
Turkish journal of ophthalmology, 2026
DOI 10.4274/tjo.galenos.2026.24196 PMID 42928578 Frei zugänglicher VolltextQuelle: Europe PMC
-
Intravitreal nintedanib attenuates proliferative vitreoretinopathy in a mouse model: Efficacy, safety, and mechanistic insights
Experimental Eye Research, 2026
DOI 10.1016/j.exer.2026.111115 PMID 42264059 Quelle: OpenAlex
-
Association between central serous chorioretinopathy and personality types: A systematic review and meta-analysis
Acta ophthalmologica, 2026
DOI 10.1111/aos.70097 PMID 41670338 Frei zugänglicher VolltextQuelle: Europe PMC
-
Association between central serous chorioretinopathy and personality types: A systematic review and meta-analysis.
Open Access CRIS of the University of Bern, 2026
DOI 10.48620/94697 Frei zugänglicher VolltextQuelle: OpenAlex
-
Does completion time of the initiation phase of anti-vascular growth factor affect visual and anatomical outcomes?: The MARMASIA study group report No.5
Eye, 2025
DOI 10.1038/s41433-025-03928-6 PMID 40664760 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Real-Life Comparison of Off-Label Intravitreal Biosimilar Bevacizumab-awwb and Reference Bevacizumab in Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion
Acibadem Universitesi Saglik Bilimleri Dergisi, 2025
DOI 10.31067/acusaglik.1528212 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID
-
Decoding the Genetic Puzzle of Inherited Retinal Dystrophies: Novel Insights From a Turkish Cohort
Clinical Genetics, 2025
DOI 10.1111/cge.14769 PMID 40371729 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Impact of the Valsalva manoeuvre on the choroid: A systematic review with meta‐analyses
Acta Ophthalmologica, 2025
DOI 10.1111/aos.16793 PMID 39503538 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Peripapillary choroidal vascularity of paediatric myopic eyes with peripapillary hyperreflective ovoid mass‐like structures
Acta Ophthalmologica, 2025
DOI 10.1111/aos.16761 PMID 39320010 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group
European Journal of Ophthalmology, 2024
DOI 10.1177/11206721241280737 PMID 39234628 Quelle: OpenAlex
-
One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13
Seminars in Ophthalmology, 2024
DOI 10.1080/08820538.2024.2324450 PMID 39087722 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Evaluation of the effect of vitreomacular interface disorders on anti-VEGF treatment in patients with diabetic macular edema in real life: MARMASIA study group report No. 10
International Ophthalmology, 2024
DOI 10.1007/s10792-024-03251-1 PMID 39317810 Quelle: OpenAlex
-
ChatGPT versus strabismus specialist on common questions about strabismus management: a comparative analysis of appropriateness and readability
Marmara Medical Journal, 2024
DOI 10.5472/marumj.1571218 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID
-
Diagnosing retinal disorders with artificial intelligence: the role of large language models in interpreting pattern electroretinography data
Journal of Health Sciences and Medicine, 2024
DOI 10.32322/jhsm.1506378 4 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID
-
Diagnostic accuracy of OCT angiography for macular neovascularization in central serous chorioretinopathy: A systematic review and meta‐analysis
Acta Ophthalmologica, 2024
DOI 10.1111/aos.16739 PMID 38988251 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
PHARC syndrome which an ultra-rare syndrome with retinitis pigmentosa and cataracts: case report and review of the literature
Ophthalmic Genetics, 2024
DOI 10.1080/13816810.2023.2289449 PMID 38186350 2 Zitationen (Europe PMC) Quelle: ORCID
-
Reply
Turkish Journal of Ophthalmology, 2024
DOI 10.4274/tjo.galenos.2023.64359 PMID 38385322 Frei zugänglicher VolltextQuelle: ORCID
-
Emotional State Evaluation of Retinitis Pigmentosa Patients with the Beck Depression Inventory
Turkish journal of ophthalmology, 2024
DOI 10.4274/tjo.galenos.2024.77489 PMID 39205424 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC
-
The role of AMP-activated protein kinase activators on energy balance and cellular metabolism in type 2 diabetes mellitus
Obesity Medicine, 2024
DOI 10.1016/j.obmed.2024.100577 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Real-life neovascular AMD treatment considering reimbursement in Turkiye: One-year comparison of switching to intravitreal ranibizumab or aflibercept after treatment failure with three loading intravitreal bevacizumab injections
Northern Clinics of Istanbul, 2024
DOI 10.14744/nci.2024.75688 PMID 39431040 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Real-World Outcomes of Intravitreal Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in Türkiye: MARMASIA Study Group Report No. 1
Turkish Journal of Ophthalmology, 2023
DOI 10.4274/tjo.galenos.2023.56249 PMID 38126607 9 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Choroidal vascularity index as an activity criterion and a treatment response measure in chronic central serous chorioretinopathy
Ophthalmic and Physiological Optics, 2023
DOI 10.1111/opo.13187 PMID 37318037 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Staphylococcus hominis: a rare cause of endophthalmitis
Arquivos brasileiros de oftalmologia, 2023
DOI 10.5935/0004-2749.20230035 PMID 35319646 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: Europe PMC
-
Dysfunctional personality beliefs and psychopathology in patients with central serous chorioretinopathy
Journal Français d Ophtalmologie, 2023
DOI 10.1016/j.jfo.2023.05.032 PMID 37919151 4 Zitationen (OpenAlex) Quelle: OpenAlex
-
A Useful Method for the Practice of Pneumatic Retinopexy: Slit-Lamp Laser Photocoagulation through the Gas Bubble
Journal of Personalized Medicine, 2023
DOI 10.3390/jpm13050741 PMID 37240912 3 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
Predictive Factors of Complications and Visual Outcomes after Pediatric Cataract Surgery: A Single Referral Center Study from Türkiye
Turkish Journal of Ophthalmology, 2023
DOI 10.4274/tjo.galenos.2023.50951 PMID 37867431 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
In vivo corneal confocal microscopy in multiple sclerosis: Can it differentiate disease relapse in multiple sclerosis?
American Journal of Ophthalmology, 2023
DOI 10.1016/j.ajo.2023.01.015 PMID 36669610 7 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID
-
Skin-Only Versus Skin-Plus-Orbicularis Resection Blepharoplasty: An Elaborated Analysis of Early- and Long-Term Effects on Corneal Nerves, Meibomian Glands, Dry Eye Parameters, and Eyebrow Position
Ophthalmic Plastic and Reconstructive Surgery, 2023
DOI 10.1097/iop.0000000000002376 PMID 36972140 7 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex
-
OCULAR PHARMACOTHERAPY IN THE ELDERLY
Turkiye Klinikleri eBooks, 2023
DOI 10.5336/978-625-395-161-0_p116 Frei zugänglicher VolltextQuelle: OpenAlex
-
Gerçek Yaşamda Diyabetik Maküla Ödemi Hastalarında Dış Retina Katman Bozukluklarının Anti-VEBF Tedavinin 12. Ay Görsel Sonuçlarına Etkisi: MARMASIA ÇALIŞMA Grubu Rapor No:15
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek yaşamda Diyabetik Maküla Ödemi Hastalarında İntravitreal Aflibercept ve Ranibizumab Tedavisinin ilk 12 ve 24 Aylık Sonuçları: MARMASIA Çalışma Grubu Rapor No.6
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Diyabetik Maküler Ödem Tedavisinde Anti-Vasküler Büyüme Faktörü Tedavisi Alan Hastalarda Yükleme Dozu Tamamlanma Süresinin Tedavi Sonucuna Etkileri: MARMARASIA Çalışma Grubu Rapor No. 5
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Diyabetik Maküla Ödeminin Optik Koherans Tomografi Paternlerinin İntravitreal Enjeksiyon Tedavisine Yanıtılarının Değerlendirilmesi: MARMASIA Çalışma Grubu Rapor No.13
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Nonproliferatif ve Proliferatif Diyabetik Retinopatili Gözlerde Optik Koherens Tomografi Belirteçlerinin Karşılaştırılması: MARMASIA Çalışma Grubu Rapor No. 2
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Diyabetik Maküla Ödemi Olan Hastalarda Vitreomaküler Arayüzey Hastalıklarının anti-VEBF Tedavisinde Etkisinin Değerlendirilmesi: MARMASIA Çalışma Grubu Rapor No. 10
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Diyabetik Maküla Ödemi Tedavisinde Arka Hyaloid Ayrışmasının Etkisi: MARMASIAÇalışma Grubu Rapor No. 11
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Pars Plana Vitrektomi Geçirmiş Gözlerde Diyabetik Maküler Ödem Tedavisinde İntravitreal Aflibercept ve Ranibizumab Tedavisinin Etkinliğinin Kısa Dönemde Değerlendirilmesi: MARMASIA Çalışma Grubu Rapor No. 12
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Diyabetik Kistoid Maküla Ödemli Hastalarda Aflibecept ve Ranibizumab Tedavisinin Kist Büyüklüğüne Olan Etkisinin Karşılaştırılması: MARMASIA Çalışma Grubu Rapor No.16
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Diyabetik Maküla Ödemi Olan Hastalarda Erken ve Geç Dönem Anti-VEBF Yanıtı ve OKT Bulgularının İlişkisi: MARMASIA Çalışma Grubu Rapor No. 4
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Aflibercept ile Tedavi Edilen Diyabetik Maküla Ödemi Hastalarında İlk 12 Ayda Yapılan Enjeksiyon Sayısının 12. ve 24. Ay Görsel Sonuçlarına Etkisi: MARMASIA Çalışma Grubu Rapor No. 3
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda İyi Görme Keskinliğine Sahip Diyabetik Maküla Ödemli Hastalarda 12 Aylık Tedavi Sonuçları: MARMASIA Çalışma Grubu Rapor No:8
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Gerçek Yaşamda Diyabetik Maküla Ödemi Tedavisi: MARMASIA Çalışma Grubu Rapor No. 1
Kocaeli Üniversitesi - AVESİS, 2022
Quelle: OpenAlex
-
Effect of age on primary balloon dacryocystoplasty and probing success in congenital nasolacrimal duct obstruction
International Ophthalmology, 2022
DOI 10.1007/s10792-022-02353-y PMID 35598226 2 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex
-
Juvenile Xanthogranuloma Presented with Buphthalmos and Corneal Clouding in Neonatal Period: A Case Report
JOURNAL OF CURRENT GLAUCOMA PRACTICE, 2022
DOI 10.5005/jp-journals-10078-1369 PMID 36128087 Frei zugänglicher VolltextQuelle: OpenAlex
-
Choroidal vascularity index changes during the Valsalva manoeuvre in healthy volunteers
Ophthalmic and Physiological Optics, 2022
DOI 10.1111/opo.12935 PMID 34913506 10 Zitationen (Europe PMC) Quelle: ORCID
-
Authors' Reply
Ophthalmic and Physiological Optics, 2022
DOI 10.1111/opo.12993 PMID 35510936 Frei zugänglicher VolltextQuelle: OpenAlex
-
Retina hastalıklarında elektrodiagnostik testlerin kullanımı
Dspace Repository (Marmara Üniversitesi), 2022
Quelle: OpenAlex
-
Straatsma Syndrome: Should Visual Prognostic Factors Be Taken into Account? A Case Report
Turkish Journal of Ophthalmology, 2021
DOI 10.4274/tjo.galenos.2021.32470 PMID 34963270 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID